Approach to the diagnosis of drug hypersensitivity reactions: Similarities and differences between Europe and North America

M. J. Torres, A. Romano, G. Celik, P. Demoly, D. A. Khan, E. Macy, Miguel Park, K. Blumenthal, W. Aberer, M. Castells, A. Barbaud, C. Mayorga, P. Bonadonna

Research output: Contribution to journalReview article

35 Citations (Scopus)

Abstract

Drug hypersensitivity reactions (DHRs) affect an unknown proportion of the general population, and are an important public health problem due to their potential to cause life-threatening anaphylaxis and rare severe cutaneous allergic reactions. DHR evaluations are frequently needed in both ambulatory and hospital settings and have a complex diagnosis that requires a detailed clinical history and other tests that may include in vitro tests and in vivo procedures such as skin tests and drug provocation tests. Although over the years both European and U.S. experts have published statements on general procedures for evaluating DHRs, a substantial discordance in their daily management exists. In this review, we highlight both the differences and the similarities between the European and U.S. perspectives. While a general consensus exists on the importance of skin tests for evaluating DHRs, concordance between Americans and Europeans exists solely regarding their use in immediate reactions and the fact that a confirmation of a presumptive diagnosis by drug provocation tests is often the only reliable way to establish a diagnosis. Finally, great heterogeneity exists in the application of in vitro tests, which require further study to be well validated.

Original languageEnglish (US)
Article number7
JournalClinical and Translational Allergy
Volume7
Issue number1
DOIs
StatePublished - Mar 13 2017

Fingerprint

Drug Hypersensitivity
North America
Skin Tests
Anaphylaxis
Pharmaceutical Preparations
Hypersensitivity
Public Health
Skin
Population
In Vitro Techniques

Keywords

  • Allergy
  • Diagnosis
  • Drug
  • Drug provocation test
  • Europe
  • Hypersensitivity
  • IgE
  • In vitro test
  • Sensitization
  • Skin test
  • T-cells
  • United States

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Approach to the diagnosis of drug hypersensitivity reactions : Similarities and differences between Europe and North America. / Torres, M. J.; Romano, A.; Celik, G.; Demoly, P.; Khan, D. A.; Macy, E.; Park, Miguel; Blumenthal, K.; Aberer, W.; Castells, M.; Barbaud, A.; Mayorga, C.; Bonadonna, P.

In: Clinical and Translational Allergy, Vol. 7, No. 1, 7, 13.03.2017.

Research output: Contribution to journalReview article

Torres, MJ, Romano, A, Celik, G, Demoly, P, Khan, DA, Macy, E, Park, M, Blumenthal, K, Aberer, W, Castells, M, Barbaud, A, Mayorga, C & Bonadonna, P 2017, 'Approach to the diagnosis of drug hypersensitivity reactions: Similarities and differences between Europe and North America', Clinical and Translational Allergy, vol. 7, no. 1, 7. https://doi.org/10.1186/s13601-017-0144-0
Torres, M. J. ; Romano, A. ; Celik, G. ; Demoly, P. ; Khan, D. A. ; Macy, E. ; Park, Miguel ; Blumenthal, K. ; Aberer, W. ; Castells, M. ; Barbaud, A. ; Mayorga, C. ; Bonadonna, P. / Approach to the diagnosis of drug hypersensitivity reactions : Similarities and differences between Europe and North America. In: Clinical and Translational Allergy. 2017 ; Vol. 7, No. 1.
@article{910d7ba862c34019a3961d344a95f642,
title = "Approach to the diagnosis of drug hypersensitivity reactions: Similarities and differences between Europe and North America",
abstract = "Drug hypersensitivity reactions (DHRs) affect an unknown proportion of the general population, and are an important public health problem due to their potential to cause life-threatening anaphylaxis and rare severe cutaneous allergic reactions. DHR evaluations are frequently needed in both ambulatory and hospital settings and have a complex diagnosis that requires a detailed clinical history and other tests that may include in vitro tests and in vivo procedures such as skin tests and drug provocation tests. Although over the years both European and U.S. experts have published statements on general procedures for evaluating DHRs, a substantial discordance in their daily management exists. In this review, we highlight both the differences and the similarities between the European and U.S. perspectives. While a general consensus exists on the importance of skin tests for evaluating DHRs, concordance between Americans and Europeans exists solely regarding their use in immediate reactions and the fact that a confirmation of a presumptive diagnosis by drug provocation tests is often the only reliable way to establish a diagnosis. Finally, great heterogeneity exists in the application of in vitro tests, which require further study to be well validated.",
keywords = "Allergy, Diagnosis, Drug, Drug provocation test, Europe, Hypersensitivity, IgE, In vitro test, Sensitization, Skin test, T-cells, United States",
author = "Torres, {M. J.} and A. Romano and G. Celik and P. Demoly and Khan, {D. A.} and E. Macy and Miguel Park and K. Blumenthal and W. Aberer and M. Castells and A. Barbaud and C. Mayorga and P. Bonadonna",
year = "2017",
month = "3",
day = "13",
doi = "10.1186/s13601-017-0144-0",
language = "English (US)",
volume = "7",
journal = "Clinical and Translational Allergy",
issn = "2045-7022",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Approach to the diagnosis of drug hypersensitivity reactions

T2 - Similarities and differences between Europe and North America

AU - Torres, M. J.

AU - Romano, A.

AU - Celik, G.

AU - Demoly, P.

AU - Khan, D. A.

AU - Macy, E.

AU - Park, Miguel

AU - Blumenthal, K.

AU - Aberer, W.

AU - Castells, M.

AU - Barbaud, A.

AU - Mayorga, C.

AU - Bonadonna, P.

PY - 2017/3/13

Y1 - 2017/3/13

N2 - Drug hypersensitivity reactions (DHRs) affect an unknown proportion of the general population, and are an important public health problem due to their potential to cause life-threatening anaphylaxis and rare severe cutaneous allergic reactions. DHR evaluations are frequently needed in both ambulatory and hospital settings and have a complex diagnosis that requires a detailed clinical history and other tests that may include in vitro tests and in vivo procedures such as skin tests and drug provocation tests. Although over the years both European and U.S. experts have published statements on general procedures for evaluating DHRs, a substantial discordance in their daily management exists. In this review, we highlight both the differences and the similarities between the European and U.S. perspectives. While a general consensus exists on the importance of skin tests for evaluating DHRs, concordance between Americans and Europeans exists solely regarding their use in immediate reactions and the fact that a confirmation of a presumptive diagnosis by drug provocation tests is often the only reliable way to establish a diagnosis. Finally, great heterogeneity exists in the application of in vitro tests, which require further study to be well validated.

AB - Drug hypersensitivity reactions (DHRs) affect an unknown proportion of the general population, and are an important public health problem due to their potential to cause life-threatening anaphylaxis and rare severe cutaneous allergic reactions. DHR evaluations are frequently needed in both ambulatory and hospital settings and have a complex diagnosis that requires a detailed clinical history and other tests that may include in vitro tests and in vivo procedures such as skin tests and drug provocation tests. Although over the years both European and U.S. experts have published statements on general procedures for evaluating DHRs, a substantial discordance in their daily management exists. In this review, we highlight both the differences and the similarities between the European and U.S. perspectives. While a general consensus exists on the importance of skin tests for evaluating DHRs, concordance between Americans and Europeans exists solely regarding their use in immediate reactions and the fact that a confirmation of a presumptive diagnosis by drug provocation tests is often the only reliable way to establish a diagnosis. Finally, great heterogeneity exists in the application of in vitro tests, which require further study to be well validated.

KW - Allergy

KW - Diagnosis

KW - Drug

KW - Drug provocation test

KW - Europe

KW - Hypersensitivity

KW - IgE

KW - In vitro test

KW - Sensitization

KW - Skin test

KW - T-cells

KW - United States

UR - http://www.scopus.com/inward/record.url?scp=85015214098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015214098&partnerID=8YFLogxK

U2 - 10.1186/s13601-017-0144-0

DO - 10.1186/s13601-017-0144-0

M3 - Review article

AN - SCOPUS:85015214098

VL - 7

JO - Clinical and Translational Allergy

JF - Clinical and Translational Allergy

SN - 2045-7022

IS - 1

M1 - 7

ER -